To explore whether TRIM56 promoted glioma cell motility by regulating CDC42 activation, we carried out Transwell chamber migration and invasion assays on glioma cells under TRIM56 overexpression and CDC42 knockdown conditions. The gene discussed is CDC42; the disease is central nervous system cancer.